Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bionxt Solutions Inc (XPHYF)

Bionxt Solutions Inc (XPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement ACCESS Newswire - Wed Jun 19, 2024

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

XPHYF : 0.2836 (-31.13%)
BNXT.CN : 0.6300 (+5.00%)
BNXTF : 0.4426 (+0.52%)
XPhyto, Biosensors Market and Product Developments on Platform-Based Oral Dissolvable Biosensors for Oral Health and Infectious Disease ACCESS Newswire - Mon Apr 11, 2022

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a market and product...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH ACCESS Newswire - Mon Dec 6, 2021

- The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology - The acquisition of 3a, a German-based rapid point-of-care...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Therapeutics Announces Stock Option Grants ACCESS Newswire - Fri Dec 3, 2021

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000 ACCESS Newswire - Fri Nov 26, 2021

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 26, 2021 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Announces CFO Appointment ACCESS Newswire - Fri Nov 19, 2021

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
DTC.CN : 0.7000 (+1.45%)
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development ACCESS Newswire - Wed Nov 3, 2021

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Reports Development Update for its Drug Delivery Business ACCESS Newswire - Tue Oct 12, 2021

- Rotigotine transdermal skin patch optimization and pivotal study planning underway - Rotigotine patch manufacturing, sales and marketing in preparation - Cannabinoid oral dissolvable film (ODF) programs...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities ACCESS Newswire - Fri Oct 8, 2021

VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered into extensions to investor relations consulting...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab ACCESS Newswire - Wed Sep 8, 2021

VANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / September 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the successful market...

XPHYF : 0.2836 (-31.13%)
XPHY.CN : 0.510 (-3.77%)

Barchart Exclusives

The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside Barchart - Sat Dec 20, 11:00AM CST
These biotech bets are only for investors who can stomach volatility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot